140 related articles for article (PubMed ID: 32937667)
1. Development and Validation of a Stability Indicating LC-MS/MS Method for the Determination of Clenbuterol HCl.
Prajapati KJ; Kothari C
Drug Res (Stuttg); 2020 Dec; 70(12):552-562. PubMed ID: 32937667
[TBL] [Abstract][Full Text] [Related]
2. Characterization of degradation products of ivabradine by LC-HR-MS/MS: a typical case of exhibition of different degradation behaviour in HCl and H2SO4 acid hydrolysis.
Patel PN; Borkar RM; Kalariya PD; Gangwal RP; Sangamwar AT; Samanthula G; Ragampeta S
J Mass Spectrom; 2015 Feb; 50(2):344-53. PubMed ID: 25800016
[TBL] [Abstract][Full Text] [Related]
3. LC-MS-MS Characterization of Forced Degradation Products of Fidarestat, a Novel Aldose Reductase Inhibitor: Development and Validation of a Stability-Indicating RP-HPLC Method.
Talluri MV; Khatoon L; Kalariya PD; Chavan BB; Ragampeta S
J Chromatogr Sci; 2015 Oct; 53(9):1588-96. PubMed ID: 26014964
[TBL] [Abstract][Full Text] [Related]
4. Isolation, Characterization, and Toxicity Study of Stress Degradation Products of Pranlukast Hydrate.
Prajapati KJ; Kothari CS
Chem Res Toxicol; 2022 Jul; 35(7):1206-1219. PubMed ID: 35731702
[TBL] [Abstract][Full Text] [Related]
5. Liquid chromatography/electrospray ionization tandem mass spectrometry study of repaglinide and its forced degradation products.
Purna Chander C; Raju B; Ramesh M; Shankar G; Srinivas R
Rapid Commun Mass Spectrom; 2018 Aug; 32(15):1181-1190. PubMed ID: 29723439
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of stress degradation products of dronedarone hydrochloride employing LC-UV/PDA, LC-MS/TOF and MS(n) studies.
Chadha R; Bali A; Bansal G
J Pharm Biomed Anal; 2016 Jan; 118():139-148. PubMed ID: 26547261
[TBL] [Abstract][Full Text] [Related]
7. Study of forced degradation behavior of enalapril maleate by LC and LC-MS and development of a validated stability-indicating assay method.
Bhardwaj SP; Singh S
J Pharm Biomed Anal; 2008 Jan; 46(1):113-20. PubMed ID: 17964751
[TBL] [Abstract][Full Text] [Related]
8. Selective separation and characterization of the stress degradation products of ondansetron hydrochloride by liquid chromatography with quadrupole time-of-flight mass spectrometry.
Talluri MV; Keshari KK; Kalariya PD; Srinivas R
J Sep Sci; 2015 May; 38(10):1625-32. PubMed ID: 25727389
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a stability-indicating high performance liquid chromatographic assay for determination of cariprazine in bulk form and in drug product.
Toujani E; Mejri W; Lassoued HE; Toujani S; Fliss O; Cheikh MHB; Safta F
Ann Pharm Fr; 2023 Jan; 81(1):83-93. PubMed ID: 36037933
[TBL] [Abstract][Full Text] [Related]
10. Stability-Indicating Reversed-Phase UHPLC Method Development and Characterization of Degradation Products of Almotriptan Maleate by LC-QTOF-MS/MS.
Saibaba B; Vishnuvardhan C; Johnsi Rani P; Satheesh Kumar N
J Chromatogr Sci; 2018 Jan; 56(1):6-17. PubMed ID: 28977362
[TBL] [Abstract][Full Text] [Related]
11. Method validation and characterization of stress degradation products of azelastine hydrochloride using LC-UV/PDA and LC-Q/TOF-MS studies.
Shekhar S; Bali A
Rapid Commun Mass Spectrom; 2024 Apr; 38(7):e9712. PubMed ID: 38351666
[TBL] [Abstract][Full Text] [Related]
12. LC-UV and LC-MS evaluation of stress degradation behaviour of tenatoprazole.
Mahadik M; Bhusari V; Kulkarni M; Dhaneshwar S
J Pharm Biomed Anal; 2009 Dec; 50(5):787-93. PubMed ID: 19615841
[TBL] [Abstract][Full Text] [Related]
13. Development of stability-indicating method for separation and characterization of benidipine forced degradation products using LC-MS/MS.
Kushwah BS; Thummar MM; Yadav AS; Dhiman V; Samanthula G
Biomed Chromatogr; 2023 Jan; 37(1):e5517. PubMed ID: 36200917
[TBL] [Abstract][Full Text] [Related]
14. Identification, characterisation and in silico ADMET prediction of ozenoxacin and its degradation products using high-performance liquid chromatography-photodiode array and liquid chromatography-quadrupole time-of-flight-tandem mass spectrometry.
Matta A; Sundararajan R
Rapid Commun Mass Spectrom; 2024 Feb; 38(3):e9676. PubMed ID: 38211348
[TBL] [Abstract][Full Text] [Related]
15. LC and LC-MS/MS studies for identification and characterization of new degradation products of ibrutinib and elucidation of their degradation pathway.
Mehta L; Naved T; Grover P; Bhardwaj M; Mukherjee D
J Pharm Biomed Anal; 2021 Feb; 194():113768. PubMed ID: 33279300
[TBL] [Abstract][Full Text] [Related]
16. Favipiravir (SARS-CoV-2) degradation impurities: Identification and route of degradation mechanism in the finished solid dosage form using LC/LC-MS method.
Vemuri DK; Gundla R; Konduru N; Mallavarapu R; Katari NK
Biomed Chromatogr; 2022 Jun; 36(6):e5363. PubMed ID: 35292997
[TBL] [Abstract][Full Text] [Related]
17. Characterization of stress degradation products of duloxetine hydrochloride employing LC-UV/PDA and LC-MS/TOF studies.
Chadha R; Bali A; Bansal G
J Pharm Biomed Anal; 2016 Mar; 121():39-55. PubMed ID: 26775018
[TBL] [Abstract][Full Text] [Related]
18. LC-MS/MS characterization of forced degradation products of zofenopril.
Ramesh T; Nageswara Rao P; Nageswara Rao R
J Pharm Biomed Anal; 2014 Jan; 88():609-16. PubMed ID: 24211724
[TBL] [Abstract][Full Text] [Related]
19. Structural characterization of alkaline and oxidative stressed degradation products of lurasidone using LC/ESI/QTOF/MS/MS.
Kumar Talluri MVN; Dharavath S; Kalariya PD; Prasanth B; Srinivas R
J Pharm Biomed Anal; 2015 Feb; 105():1-9. PubMed ID: 25527975
[TBL] [Abstract][Full Text] [Related]
20. Identification of hydrolytic and isomeric N-oxide degradants of vilazodone by on line LC-ESI-MS/MS and APCI-MS.
Kalariya PD; Talluri MV; Patel PN; Srinivas R
J Pharm Biomed Anal; 2015 Jan; 102():353-65. PubMed ID: 25459935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
